Guerrero Ramiro 4/A
4/A · MAIA Biotechnology, Inc. · Filed Mar 5, 2025
Insider Transaction Report
Form 4/AAmended
Guerrero Ramiro
Director
Transactions
- Purchase
Warrants
2025-02-24$1.87/sh+73,333$137,133→ 73,333 totalExercise: $1.87From: 2026-02-25Exp: 2031-02-25→ Common Stock (73,333 underlying) - Purchase
Common Stock
2025-02-24$1.50/sh+73,333$110,000→ 534,885.04 total
Footnotes (3)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plna on February 24, 2025.
- [F2]This Form 4/A is being filed to correct the "Date Exercisable" and "Expiration Date" in Section 6 of Table II reported in the original Form 4 filed on February 25, 2025 as well as to correct the date of the Securities Purchase Agreement orginally referenced in the footnote 1 and 2 to "February 24, 2025".
- [F3]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on February 24, 2025. The options are exercisable beginning on the one-year anniversary of the issuance date and expire 6-years after the initial issuance date.